Federal Register of Legislation - Australian Government

Primary content

PB 44 of 2021 Arrangements as made
This instrument amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015) to add, delete and make changes to the drugs listed in Schedule 1, including the associated forms, manners of administration, brands and section 100 only status.
Administered by: Health
Registered 30 Apr 2021
Tabling HistoryDate
Tabled HR11-May-2021
Tabled Senate11-May-2021
To be repealed 12 Aug 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

PB 44 of 2021

 

National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.

Dated         28 April               2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BEN SLADIC

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

 

 


 

___________________________________________________________________________

1          Name of Instrument

(1)          This instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1)

(2)          This instrument may also be cited as PB 44 of 2021.

2          Commencement

This instrument commences on 1 May 2021.

3          Amendment of National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015)

Schedule 1 amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015).

 


Schedule 1       Amendments

 

[1]        Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative)

omit:

 

 

 

Norditropin

SimpleXx

D(100)

[2]        Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative)

omit:

 

 

 

Norditropin

SimpleXx

D(100)

[3]        Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 15 mg (45 i.u.) in 1.5 mL cartridge (with preservative)

omit:

 

 

 

Norditropin

SimpleXx

D(100)